This fellowship is being offered by the Department of Oncology, for a clinician wishing to undertake a clinical DPhil. The purpose of the fellowship is to allow an oncologist to pursue clinical academic research in device-enhanced oncological drug delivery.
The project will centre on the development of ultrasound-enhanced oncological drug delivery. There may also be an opportunity to become involved in other trials of ablative therapies and isolated hepatic perfusion. In addition to your medical qualification, you will have received (or be about to receive) a postgraduate qualification in oncology. You will have a national training number. Applicants will be considered on the basis of their academic achievements and potential.
The successful applicant will be expected to interact with biomedical engineers and other basic scientists, drawing on their expertise, to optimise clinical protocols for targeted drug delivery using ultrasound. This 3-year post will give the opportunity for a dedicated academic trainee to take a leading role in conducting clinical trials using ultrasound therapy.
A primary medical degree (MB, ChB or equivalent) is essential for this role, as well as being a GMC registered Medical Practitioner with full-time hospital service as an SHO or higher grade. You will also hold or have completed all the necessary qualifications in order to hold a UK Personal Licence.
This is a full-time post, fixed-term until the end of March 2020 in the first instance, with the possibility of extension until the end of July 2021.
All applicants must complete an application form and submit a CV and supporting statement.
The closing date for applications is 12.00 noon on 22 November 2018.